Jonathan Young - 07 Jan 2022 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Chief Operating Officer
Signature
/s/ Jonathan Young
Issuer symbol
AKRO
Transactions as of
07 Jan 2022
Net transactions value
+$17,063
Form type
4
Filing time
11 Jan 2022, 15:40:27 UTC
Previous filing
10 Dec 2021
Next filing
13 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Options Exercise $17,063 +27,744 +20% $0.6150* 163,254 07 Jan 2022 Direct
holding AKRO Common Stock 20,000 07 Jan 2022 By EA Irrevocable Trust F1
holding AKRO Common Stock 20,000 07 Jan 2022 By CM Irrevocable Trust F1
holding AKRO Common Stock 20,000 07 Jan 2022 By JL Irrevocable Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Employee Stock Option (Right to Buy) Options Exercise $0 -26,296 -100% $0.000000* 0 07 Jan 2022 Common Stock 26,296 $0.6150 Direct F2
transaction AKRO Employee Stock Option (Right to Buy) Options Exercise $0 -1,448 -1.5% $0.000000 92,820 07 Jan 2022 Common Stock 1,448 $0.6150 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in irrevocable trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 25% of this option vested on August 1, 2018 and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.
F3 Shares vested and became exercisable in equal monthly installments for a period of 48 months following October 1, 2018.